UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 13, 2024 SANUWAVE Health, Inc. | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Nevada | 000-52985 | 20-1176000 | | (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | 11495 Valley View Road ...

November 8, 2024 Q3 FY2024 Participant Dial-in Information Toll Free: 1-800-267-6316 Toll/International: 1-203-518-9783 Conference ID: SANUWAVE OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1692398&tp_key=e3cff43c54 Live Presentation Friday, November 8, 2024, 8:30 AM (ET) Replay Dial-in Information Toll Free: 1-844-512-2921 Toll/International: 1-412-317-6671 Replay Pin Number: 11157276 Replay Expiry: November 29, 2024 2 Forward Looking Statements T ...

Q4 FY2024 March 21, 2025 Replay Dial-in Information Live Presentation Friday, March 21, 2025, 8:30 AM (ET) Participant Dial-in Information Toll Free: 1-800-245-3047 Toll/International: 1-203-518-9765 Conference ID: SANUWAVE OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1703280&tp_key=c099e4f4d9 Toll Free: 1-844-512-2921 Toll/International: 1-412-317-6671 Replay Expiry: April 11, 2025 2 Forward Looking Statements and Non-GAAP Financial Measures Forw ...

Toll Free: 1-800-245-3047 Toll/International: 1-203-518-9765 Conference ID: SANUWAVE Q1 FY2025 May 9, 2025 Live Presentation Friday, May 9, 2025, 8:30 AM (ET) Participant Dial-in Information OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1714486&tp_key=88406b4795 Replay Dial-in Information Toll Free: 1-844-512-2921 Toll/International: 1-412-317-6671 Replay Pin Number: 11158734 Replay Expiry: May 30, 2025 2 Forward Looking Statements and Non-GAAP Fin ...

Sanuwave Health (SNWV) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Company Participants Morgan Frank - Chairman & CEOPeter Sorensen - CFOAlbert Hanser - Managing PartnerChristopher Davis - Managing DirectorIan Cassel - Founder/Cheif Investment Officer Conference Call Participants Carl Byrnes - Managing Director, Senior Research Analyst Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity ...

Sanuwave Health (SNWV) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Speaker0 Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask questions during the question and answer session. Please note today's call will be recorded and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Chairman and CEO of SANUWAVE, Morgan Frank. Please go ahead. ...

Financial Results - Sanuwave Health, Inc. announced preliminary financial results for Q1 2025 on April 8, 2025[4] - The press release detailing financial results is attached as Exhibit 99.1[6] - The report indicates that the information provided is not deemed "filed" under the Securities Exchange Act of 1934[5] Company Information - The company is registered under the trading symbol SNWV on The Nasdaq Stock Market LLC[2] - The Chief Financial Officer, Peter Sorensen, signed the report on behalf of the company[10]

Q1 2025 revenues were $9.3 million, up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0%, versus 72.6% in Q1 2024. GAAP Operating Income was $1.0 million for Q1 2025, an increase of $2.0 million from Q1 2024. Company provides guidance for revenue growth of 40-50% for Q2 2025 as compared to Q2 2024 EDEN PRAIRIE, Minn., May 09, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a le ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Table of Contents o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to Commission File Number 000-52985 SANUWAVE Health, Inc. (Exact name of registrant as specified in its charter) Nevada 20-1176000 (St ...

Group 1 - Sanuwave Health, Inc. will host a live conference call on May 9, 2025, at 8:30 AM (ET) to present its Q1 2025 financial results [1][2] - The company specializes in next-generation FDA-approved wound care products and is focused on the research, development, and commercialization of non-invasive medical systems [2][3] - Sanuwave's product portfolio includes regenerative medicine products aimed at restoring normal healing processes in various medical conditions [3] Group 2 - The conference call will provide access via toll-free and international numbers, with a replay available until May 30, 2025 [1][2] - Materials related to the conference call will be accessible on the company's investor website [2] - Sanuwave applies patented energy transfer technologies in multiple fields, including wound healing and orthopedic conditions [3]